Literature DB >> 7560600

Family history of severe cardiovascular disease in Marfan syndrome is associated with increased aortic diameter and decreased survival.

D I Silverman1, J Gray, M J Roman, A Bridges, K Burton, M Boxer, R B Devereux, P Tsipouras.   

Abstract

OBJECTIVES: We attempted to determine whether a family history of severe cardiovascular disease in patients with the Marfan syndrome is associated with increased aortic dilation or decreased survival, or both.
BACKGROUND: The prognostic importance of a family history of severe cardiovascular disease in patients with the Marfan syndrome has been incompletely examined. We hypothesized that such a family history would correlate with increased aortic dilation and would be associated with decreased survival.
METHODS: One hundred eight affected patients and 48 unaffected family members from 33 multigenerational families with the Marfan syndrome underwent echocardiographic measurement of the aortic root, arch and mid-abdominal aorta. Date of birth and age at death ascertained from family pedigrees were used to perform life table analysis and estimate survival.
RESULTS: Aortic root and arch diameters were significantly greater in patients with a family history of severe cardiovascular disease than in patients without such a family history. Of subjects in the highest quartile for aortic size, > 80% had such a family history in contrast to < 10% of those in the lowest quartile (chi-square 57.37, p < 0.00001). Mean age at death and cumulative probability of survival were significantly lower in patients with such a family history.
CONCLUSIONS: Among patients with the Marfan syndrome, aortic dilation is greater and life expectancy shorter in those with a family history of severe cardiovascular manifestations. These data suggest that such a family history is an important risk factor for cardiovascular events in patients with the Marfan syndrome.

Entities:  

Mesh:

Year:  1995        PMID: 7560600     DOI: 10.1016/0735-1097(95)00258-0

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  16 in total

1.  Survival and complication free survival in Marfan's syndrome: implications of current guidelines.

Authors:  M Groenink; T A Lohuis; J G Tijssen; M S Naeff; R C Hennekam; E E van der Wall; B J Mulder
Journal:  Heart       Date:  1999-10       Impact factor: 5.994

Review 2.  Genetic testing in aortic aneurysm disease: PRO.

Authors:  Dianna M Milewicz; Alicia A Carlson; Ellen S Regalado
Journal:  Cardiol Clin       Date:  2010-05       Impact factor: 2.213

Review 3.  The molecular genetics of Marfan syndrome and related microfibrillopathies.

Authors:  P N Robinson; M Godfrey
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

4.  The prevalence and clinical impact of obesity in adults with Marfan syndrome.

Authors:  Anji T Yetman; Brian W McCrindle
Journal:  Can J Cardiol       Date:  2010-04       Impact factor: 5.223

5.  Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan's syndrome.

Authors:  Candice K Silversides; Marla Kiess; Luc Beauchesne; Timothy Bradley; Michael Connelly; Koichiro Niwa; Barbara Mulder; Gary Webb; Jack Colman; Judith Therrien
Journal:  Can J Cardiol       Date:  2010-03       Impact factor: 5.223

Review 6.  Drug-based therapies for vascular disease in Marfan syndrome: from mouse models to human patients.

Authors:  Jason R Cook; Harikiran Nistala; Francesco Ramirez
Journal:  Mt Sinai J Med       Date:  2010 Jul-Aug

7.  A new mouse model for marfan syndrome presents phenotypic variability associated with the genetic background and overall levels of Fbn1 expression.

Authors:  Bruno L Lima; Enrico J C Santos; Gustavo R Fernandes; Christian Merkel; Marco R B Mello; Juliana P A Gomes; Marina Soukoyan; Alexandre Kerkis; Silvia M G Massironi; José A Visintin; Lygia V Pereira
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

Review 8.  Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis.

Authors:  Jeffrey A Jones; Francis G Spinale; John S Ikonomidis
Journal:  J Vasc Res       Date:  2008-09-02       Impact factor: 1.934

9.  Marfan syndrome in children and adolescents: predictive and prognostic value of aortic root growth for screening for aortic complications.

Authors:  M Groenink; L Rozendaal; M S Naeff; R C Hennekam; A A Hart; E E van der Wall; B J Mulder
Journal:  Heart       Date:  1998-08       Impact factor: 5.994

Review 10.  Cardiovascular magnetic resonance in Marfan syndrome.

Authors:  Helen Dormand; Raad H Mohiaddin
Journal:  J Cardiovasc Magn Reson       Date:  2013-04-15       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.